Coldstream Capital Management Inc Penumbra Inc Transaction History

Coldstream Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$220.09 - $273.15 $8,803 - $10,926	40 Added 4.01%	1,037 $231,000
Q4 2023 Feb 09, 2024	SELL	$181.44 - $260.22 $8,527 - $12,230	-47 Reduced 4.5%	997 $250,000
Q3 2023 Nov 02, 2023	BUY	$240.69 - $338.77 $1,444 - $2,032	6 Added 0.58%	1,044 $252,000
Q2 2023 Aug 03, 2023	SELL	$271.54 - $344.06 $19,007 - $24,084	-70 Reduced 6.32%	1,038 $357,000
Q1 2023 May 15, 2023	SELL	$220.43 - $278.69 $10,580 - $13,377	-48 Reduced 4.15%	1,108 $308,000
Q4 2022 Jan 10, 2023	BUY	$151.88 - $228.5 $175,573 - $264,146	1,156 New	1,156 $0
Q1 2022 May 11, 2022	SELL	$187.51 - $283.98 $163,508 - $247,630	-872 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$238.08 - $288.0 $207,605 - $251,136	872 New	872 $251,000

383

29.6M

285K

168K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $7.36B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Coldstream Capital Management Inc with notifications on news.